MENU

Why the Queensland Bauxite Ltd share price stormed 20% higher today

The Queensland Bauxite Ltd (ASX: QBL) share price is having a strong day ahead of the Christmas break.

In morning trade the bauxite miner and medicinal cannabis company’s shares are up 20% to 6 cents.

What happened?

Once again, today’s move higher has nothing to do with bauxite and everything to do with its interest in the medicinal cannabis sector through its Medical Cannabis Limited business.

According to an announcement out of the company this morning, it has signed an agreement with Algae Tec Ltd (ASX: AEB) to exclusively license Medical Cannabis’ low THC Delta 9 cultivars from its unique Australian Cannabis seed bank.

Algae Tec will look to establish a breeding program to identify cultivars for use in cannabinoid product development to research and develop stock and veterinary medications, supplements, and sophisticated animal therapeutics.

This brings the company into direct competition with fellow pot stocks Creso Pharma Ltd (ASX: CPH) and Cannpal Animal Therapeutics Ltd (ASX: CP1) which are also active in the companion animal health space.

Algae Tec’s shares are up 25% on the news.

Should you invest?

I wouldn’t be in a rush to invest in either Queensland Bauxite or Algae Tec just yet. Whilst there is a huge opportunity in the veterinary market, I feel other pot stocks are better positioned to challenge the current status quo.

But it may be worthwhile keeping a close eye on the company next year, despite how odd the bauxite-cannabis mix is.

Finally, here are three hot stocks that I am ready to buy today.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.